Claire Mazumdar

Chief Executive Officer, Director, Bicara Therapeutics Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$3.1M

Companies

Latest trade

Aug 10, 2026

Companies

Bicara Therapeutics Inc.Chief Executive Officer, Director −$4.1M

Trades

BCAX Sold 10,000 shares at $27.98 · planned $0.3M Aug 10

BCAX Sold 10,000 shares at $28.42 · planned $0.3M Jul 10

BCAX Sold 15,000 shares at $20.04 · planned $0.3M May 18

BCAX Sold 15,000 shares at $23.61 · planned $0.4M Apr 20

BCAX Sold 1,596 shares at $18.95 · planned $0.0M Mar 20

BCAX Sold 6,905 shares at $18.78 · planned $0.1M Mar 19

BCAX Sold 6,499 shares at $18.84 · planned $0.1M Mar 18

BCAX Sold 36,766 shares at $19.17 · planned $0.7M Mar 9

BCAX Sold 3,817 shares at $18.75 · planned $0.1M Mar 6

BCAX Sold 1,786 shares at $18.74 · planned $0.0M Mar 5

BCAX Sold 2,631 shares at $18.73 · planned $0.0M Mar 4

BCAX Sold 41,163 shares at $18.86 · planned $0.8M Nov 24

BCAX Sold 24,103 shares at $18.83 · planned $0.5M Oct 16

BCAX Sold 13,289 shares at $18.84 · planned $0.3M Oct 15

BCAX Sold 11,445 shares at $18.92 · planned $0.2M Oct 13

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.